In most retinal diseases, neuronal loss is the main cause of vision loss. Neuroprotection is the alteration of neurons and/or their environment to encourage the survival and function of the neurons, especially in environments that are deleterious to the neuronal health. The area of neuroprotection progresses with a therapeutically-based hope of improving vision and clinical outcomes for patients through the developments in neurotrophic therapy, antioxidative therapy, anti-excitotoxic, anti-ischemic, anti-inflammatory, and anti-apoptotic care. In this review, we summarize the various neuroprotection strategies for the treatment of glaucoma, genetics of glaucoma and the role of various nanoplatforms in the treatment of glaucoma.

Original languageEnglish
Article number173208
JournalEuropean Journal of Pharmacology
Publication statusPublished - 15-08-2020

All Science Journal Classification (ASJC) codes

  • Pharmacology


Dive into the research topics of 'Neuroprotection: A versatile approach to combat glaucoma'. Together they form a unique fingerprint.

Cite this